5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.30▲ | 2.29▲ | 2.30▼ | 2.31▼ | 2.53▼ |
MA10 | 2.29▲ | 2.31▼ | 2.31▼ | 2.37▼ | 2.62▼ |
MA20 | 2.31▼ | 2.30▼ | 2.30▼ | 2.49▼ | 2.84▼ |
MA50 | 2.30▼ | 2.29▲ | 2.36▼ | 2.62▼ | 3.16▼ |
MA100 | 2.30▼ | 2.37▼ | 2.43▼ | 2.85▼ | 3.10▼ |
MA200 | 2.31▼ | 2.45▼ | 2.53▼ | 3.25▼ | 3.68▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | -0.001▼ | 0.004▲ | -0.017▼ | -0.040▼ |
RSI | 48.541▼ | 49.108▼ | 46.301▼ | 36.341▼ | 34.111▼ |
STOCH | 66.111 | 21.978 | 42.857 | 27.025 | 25.983 |
WILL %R | -33.333 | -71.429 | -71.429 | -79.964▼ | -90.185▼ |
CCI | -0.869 | -22.304 | -33.333 | -94.308 | -195.053▼ |
Friday, March 14, 2025 10:39 PM
Albertsons Companies (NYSE:ACI – Get Free Report) had its price objective raised by research analysts at Royal Bank of Canada from $22.00 to $23.00 in a report issued on Thursday,Benzinga reports. The ...
|
Thursday, March 13, 2025 12:59 PM
AC Immune to Participate in Upcoming Investor Conferences Lausanne, Switzerland, March 4, 2025 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision ...
|
Thursday, March 13, 2025 12:55 PM
AC IMMUNE SA ($ACIU) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.16 per share, beating estimates of -$0.19 by $0. ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/03/25 | 2.33 | 2.3579 | 2.27 | 2.29 | 142,200 |
13/03/25 | 2.35 | 2.38 | 2.2221 | 2.30 | 164,995 |
12/03/25 | 2.25 | 2.34 | 2.21 | 2.32 | 145,929 |
11/03/25 | 2.42 | 2.42 | 2.19 | 2.25 | 261,290 |
10/03/25 | 2.50 | 2.55 | 2.38 | 2.395 | 179,097 |
07/03/25 | 2.47 | 2.5293 | 2.4036 | 2.41 | 218,752 |
06/03/25 | 2.53 | 2.53 | 2.45 | 2.49 | 202,327 |
05/03/25 | 2.36 | 2.52 | 2.36 | 2.50 | 351,734 |
04/03/25 | 2.36 | 2.3991 | 2.31 | 2.35 | 151,035 |
03/03/25 | 2.53 | 2.555 | 2.38 | 2.40 | 232,270 |
|
|
||||
|
|
||||
|
|